ArticleDiabetes care2026

Glucocorticoids to Manage Cytokine Release Syndrome During Teplizumab Therapy for New-Onset Type 1 Diabetes.

Aye Khine et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.